Tatyana Balakhonova

Prof. Tatyana Balakhonova

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2021 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
EPElizaveta Panchenko
Elizaveta Panchenko
TBTatyana Balakhonova
Tatyana Balakhonova
NDN. M. Danilov
N. M. Danilov
AKA. L. Komarov
A. L. Komarov
EKE. S. Kropachyova
E. S. Kropachyova
IYI. S. Yavelov
I. S. Yavelov
Disclaimer.The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the EAC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the EAC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the EAC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the EAC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

16 July 2021 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
AEAlexandra Ershova
Alexandra Ershova
TBTatyana Balakhonova
Tatyana Balakhonova
Alexey MeshkovAlexey Meshkov
Alexey Meshkov
VKVladimir Kutsenko
Vladimir Kutsenko
Elena YarovayaElena Yarovaya
Elena Yarovaya
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. To study the prevalence of carotid (CA) and femoral artery (FA) atherosclerosis among Russian population, mainly in middle age group, using a representative sample of one of the Central Russian regions.Material and methods. The analysis included participants of the ATEROGEN-Ivanovo study (sub-study of the ESSE-RF conducted in the Ivanovo region) aged 40-67 years, who were invited for CA and FA ultrasound to assess plaque presence. A total 1102 people were examined, which was >80% of the original sample.Results. The age of subjects was 54 [48; 60] years (men, 28%). Only 11,2% of participants took statins; 30,9% had low cardiovascular risk (CVR), 35,6% — moderate CVR, 21,8% — high CVR, and 11,8% — very high CVR. The incidence of at least one plaque in CA or FA was 73,6%. The prevalence of CA atherosclerosis was 76,4% in men and 59,1% in women, FA atherosclerosis — 54,9% and 28,3%, respectively. Furthermore, plaques were detected already at the age of 40. The incidence of plaques significantly increased with age, with the exception of carotid atherosclerosis in men, a significant increase in the incidence of which stopped at 45 years of age.Conclusion. Among the Ivanovo population aged 40-67 with a predominance of low-to-moderate CVR patients, there is a high prevalence of carotid and femoral atherosclerosis, which indicates a high potential for using ultrasound for diagnosing subclinical atherosclerosis in assessing CVR in people of this age range.

Verified
Journal Article
Open access
PDF file
NTNarek Tmoyan
Narek Tmoyan
OAOlga Afanasieva
Olga Afanasieva
Marat EzhovMarat Ezhov
Marat Ezhov
EKElena Klesareva
Elena Klesareva
TBTatyana Balakhonova
Tatyana Balakhonova
SPSergei N. Pokrovsky
Sergei N. Pokrovsky
Background and aims: lipoprotein(a) (Lp(a)) is a genetically determined risk factor for coronary artery disease and its complications, although data on the association with other vascular beds and the severity of atherosclerosis is limited. The aim of this study was to evaluate the association of atherosclerosis of various vascular beds with Lp(a), as well as its autoantibodies and generalized inflammatory markers. Material and methods: this study included 1288 adult patients with clinical and imaging examination of three vascular beds (coronary, carotid, and lower limb arteries). Patients were categorized according to the number of affected vascular beds (with at least one atherosclerotic stenosis ≥50%): 0 (n = 339), 1 (n = 470), 2 (n = 315), 3 (n = 164). We assessed blood cell count, lipid profile, C-reactive protein, circulating immune complexes, Lp(a), and its autoantibodies. Results: the number of affected vascular beds was associated with an increasing level of Lp(a) and a lower level of IgM autoantibodies to Lp(a). Hyperlipoproteinemia(a) (Lp(a) ≥ 30 mg/dL) was detected more frequently in patients with atherosclerosis. In logistic regression analysis adjusted for age, sex, hypertension, type 2 diabetes, and smoking, an elevated Lp(a) level was independently associated with stenotic atherosclerosis and lesion severity. There was a positive association of the number of affected vascular beds with C-reactive protein (r = 0.21, p < 0.01) and a negative association with circulating immune complexes (r = −0.29, p < 0.01). The neutrophil-to-lymphocyte ratio was significantly higher and the lymphocyte-to-monocyte ratio was significantly lower in patients with atherosclerosis compared to the controls (p < 0.01). Conclusion: Lp(a), C-reactive protein, circulating immune complexes, and neutrophil-to-lymphocyte ratio are associated with the stenotic atherosclerosis of different vascular beds. Lp(a) levels increase and IgM autoantibodies to Lp(a) decrease with the number of affected vascular beds.

22 October 2020 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
DODmitrii Ognerubov
Dmitrii Ognerubov
ASAlexander Sedaghat
Alexander Sedaghat
SPSergey Provatorov
Sergey Provatorov
ATAndrey Tereshchenko
Andrey Tereshchenko
OBOlivier Bertrand
Olivier Bertrand
EMEvgeny Merkulov
Evgeny Merkulov
Background. Despite the enormous benefits of radial access, this route is associated with a risk of radial artery occlusion (RAO). Objective. We compared the incidence of RAO in patients undergoing transradial coronary angiography and intervention after short versus prolonged hemostasis protocol. Also we assessed the efficacy of rescue 1-hour ipsilateral ulnar artery compression if RAO was observed after hemostasis. Material and Methods. Patients referred for elective transradial coronary procedures were eligible. After 6 F radial sheath removal, patients were randomized to short (3 hours) (n = 495) or prolonged (8 hours) (n = 503) hemostasis and a simple bandage was placed over the puncture site. After hemostasis was completed, oximetry plethysmography was used to assess the patency of the radial artery. Results. One thousand patients were randomized. Baseline characteristics were similar between both groups with average age 61.4 ± 9.4 years (71% male) and PCI performed on half of the patients. The RAO rate immediately after hemostasis was 3.2% in the short hemostasis group and 10.1% in the prolonged group ( ). Rescue recanalization was successful only in the short group in 56.2% (11/19); at hospital discharge, RAO rates were 1.4% in the short group and 10.1% in the prolonged group ( ). Conclusion. Shorter hemostasis was associated with significantly less RAO compared to prolonged hemostasis. Rescue radial artery recanalization was effective in > 50%, but only in the short hemostasis group.

20 August 2018 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
AEAlexandra Ershova
Alexandra Ershova
Alexey MeshkovAlexey Meshkov
Alexey Meshkov
ADA. D. Deev
A. D. Deev
EAE. L. Aleksandrova
E. L. Aleksandrova
NLN. E. Lishchenko
N. E. Lishchenko
SBSergey Boytsov
Sergey Boytsov
Атеросклеротическая бляшка в сонных артериях как маркер риска развития сердечно-сосудистых событий в популяции среднего возраста

21 April 2020 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
AEAlexandra Ershova
Alexandra Ershova
TBTatyana Balakhonova
Tatyana Balakhonova
AIA. A. Ivanova
A. A. Ivanova
Alexey MeshkovAlexey Meshkov
Alexey Meshkov
SBSergey Boytsov
Sergey Boytsov
ODOxana M. Drapkina
Oxana M. Drapkina
Проблема стратификации сердечно-сосудистого риска в зависимости от выраженности атеросклероза сонных и бедренных артерий